SAB Property Plant And Equipment Gross from 2010 to 2024

SABS Stock  USD 3.85  0.40  9.41%   
SAB Biotherapeutics Property Plant And Equipment Gross yearly trend continues to be comparatively stable with very little volatility. Property Plant And Equipment Gross will likely drop to about 27.7 M in 2024. From the period from 2010 to 2024, SAB Biotherapeutics Property Plant And Equipment Gross quarterly data regression had r-value of  0.79 and coefficient of variation of  58.49. View All Fundamentals
 
Property Plant And Equipment Gross  
First Reported
2010-12-31
Previous Quarter
34.6 M
Current Value
27.7 M
Quarterly Volatility
9.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SAB Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SAB Biotherapeutics' main balance sheet or income statement drivers, such as Interest Income of 80.1 K, Depreciation And Amortization of 2.1 M or Interest Expense of 289.4 K, as well as many indicators such as Price To Sales Ratio of 16.12, Dividend Yield of 0.0 or PTB Ratio of 0.7. SAB financial statements analysis is a perfect complement when working with SAB Biotherapeutics Valuation or Volatility modules.
  
Check out the analysis of SAB Biotherapeutics Correlation against competitors.
For more information on how to buy SAB Stock please use our How to Invest in SAB Biotherapeutics guide.

Latest SAB Biotherapeutics' Property Plant And Equipment Gross Growth Pattern

Below is the plot of the Property Plant And Equipment Gross of SAB Biotherapeutics over the last few years. It is SAB Biotherapeutics' Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SAB Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Gross10 Years Trend
Slightly volatile
   Property Plant And Equipment Gross   
       Timeline  

SAB Property Plant And Equipment Gross Regression Statistics

Arithmetic Mean16,307,307
Geometric Mean14,242,507
Coefficient Of Variation58.49
Mean Deviation8,272,350
Median10,103,044
Standard Deviation9,538,068
Sample Variance91T
Range24.5M
R-Value0.79
Mean Square Error36.4T
R-Squared0.63
Significance0.0004
Slope1,690,975
Total Sum of Squares1273.6T

SAB Property Plant And Equipment Gross History

202427.7 M
202334.6 M
202223.3 M
202134.2 M
202023.9 M

About SAB Biotherapeutics Financial Statements

SAB Biotherapeutics shareholders use historical fundamental indicators, such as Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Although SAB Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in SAB Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on SAB Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Property Plant And Equipment Gross34.6 M27.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for SAB Stock Analysis

When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.